- Hepion Pharmaceuticals (HEPA) +75% after CRV431 prevents cirrhosis in experimental model of severe liver disease.
- TD Ameritrade Holding (AMTD) +24% on Schwab buyout report.
- Stage Stores (SSI) +22% on Q3 earnings.
- Bio-Path Holdings (BPTH) +22% after FDA clears IND for BP1002.
- Anaplan (PLAN) +14% on Q3 earnings.
- The Charles Schwab (SCHW) +10% on Schwab buyout report.
- Celyad SA (CYAD) +10%.
- Canopy Growth (CGC) +8% following House passage of a pot decriminalization bill.
- Nuance Communications (NUAN) +8% on Q4 earnings.
- Westwater Resources (WWR) +7% on engaging Dorfner Anzaplan to accelerate product development and design for Graphite pilot program.
- SunPower (SPWR) +6%.
- Star Bulk Carriers (SBLK) +6%. on Q3 earnings.
- Tilray (TLRY) +6% following House passage of a pot decriminalization bill.
- Copart (CPRT) +6% on Q1 earnings.
- Cronos Group (CRON) +6% following House passage of a pot decriminalization bill.